Pulse Biosciences, Inc. Notes Payable, Related Parties, Current
Pulse Biosciences, Inc. (PLSE) had Notes Payable, Related Parties, Current of $917.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes
us-gaap:NotesPayableRelatedPartiesClassifiedCurrent · last filed 2023-03-31
- 2022-12-31: Notes Payable, Related Parties, Current $917.00K.
- 2022-09-30: Notes Payable, Related Parties, Current $98.00K.
- 2021-12-31: Notes Payable, Related Parties, Current $0.00.
| Period end | Notes Payable, Related Parties, Current |
|---|---|
| 2022-12-31 | $917.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $98.00K 10-Q · filed 2022-11-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |